ASX - By Stock
|
ACW |
Re:
Ann: First patient treated in ACW XanaMIA ph 2b Alzheimers trial
|
|
Lait
|
26 |
8.3K |
8 |
25/04/24 |
25/04/24 |
ASX - By Stock
|
26
|
8.3K
|
8
|
|
ASX - By Stock
|
NUC |
Re:
Ann: Quarterly Activities Report & Appendix 4C
|
|
Lait
|
1 |
249 |
0 |
24/04/24 |
24/04/24 |
ASX - By Stock
|
1
|
249
|
0
|
|
ASX - By Stock
|
MX1 |
Re:
Ann: Trading Halt
|
|
Lait
|
14 |
4.7K |
2 |
15/04/24 |
15/04/24 |
ASX - By Stock
|
14
|
4.7K
|
2
|
|
ASX - By Stock
|
ART |
Re:
ASX: ART ( AIRTASKER ); Operational restructure and path to sustained profitability
|
|
Lait
|
12 |
3.5K |
3 |
10/02/24 |
10/02/24 |
ASX - By Stock
|
12
|
3.5K
|
3
|
|
ASX - By Stock
|
MX1 |
Re:
Ann: MX1 - Quarterly Cashflows and Activity Statement
|
|
Lait
|
6 |
2.7K |
4 |
01/02/24 |
01/02/24 |
ASX - By Stock
|
6
|
2.7K
|
4
|
|
ASX - By Stock
|
MX1 |
Re:
Ann: MX1 - AGM CEO Presentation
|
|
Lait
|
19 |
9.9K |
1 |
10/01/24 |
10/01/24 |
ASX - By Stock
|
19
|
9.9K
|
1
|
|
ASX - By Stock
|
MX1 |
Re:
Ann: MX1 - AGM CEO Presentation
|
|
Lait
|
19 |
9.9K |
5 |
04/01/24 |
04/01/24 |
ASX - By Stock
|
19
|
9.9K
|
5
|
|
ASX - By Stock
|
MX1 |
Re:
Ann: MX1 - $1.5M Rover order from Australian Government
|
|
Lait
|
13 |
7.4K |
1 |
28/10/23 |
28/10/23 |
ASX - By Stock
|
13
|
7.4K
|
1
|
|
ASX - By Stock
|
ACW |
Re:
Ann: Actinogen enhances XanaMIA Phase 2b Alzheimers trial
|
|
Lait
|
6 |
2.9K |
4 |
28/09/23 |
28/09/23 |
ASX - By Stock
|
6
|
2.9K
|
4
|
|
ASX - By Stock
|
ART |
Re:
News: ART Airtasker Says On Track For Positive Free Cashflow Result In FY24
|
|
Lait
|
13 |
5.3K |
1 |
11/09/23 |
11/09/23 |
ASX - By Stock
|
13
|
5.3K
|
1
|
|
ASX - By Stock
|
ART |
Re:
News: ART Airtasker Says On Track For Positive Free Cashflow Result In FY24
|
|
Lait
|
13 |
5.3K |
1 |
08/09/23 |
08/09/23 |
ASX - By Stock
|
13
|
5.3K
|
1
|
|
ASX - By Stock
|
MX1 |
Re:
Ann: MX1 - Strategy Refresh Presentation
|
|
Lait
|
21 |
7.5K |
0 |
13/08/23 |
13/08/23 |
ASX - By Stock
|
21
|
7.5K
|
0
|
|
ASX - By Stock
|
MX1 |
Re:
Ann: MX1 - Strategy Refresh Presentation
|
|
Lait
|
21 |
7.5K |
2 |
13/08/23 |
13/08/23 |
ASX - By Stock
|
21
|
7.5K
|
2
|
|
ASX - By Stock
|
MX1 |
Re:
Ann: MX1 - Strategy Refresh Presentation
|
|
Lait
|
21 |
7.5K |
5 |
13/08/23 |
13/08/23 |
ASX - By Stock
|
21
|
7.5K
|
5
|
|
ASX - By Stock
|
ART |
Re:
Ann: Channel 4 Media Partnership Webcast
|
|
Lait
|
7 |
2.1K |
4 |
17/06/23 |
17/06/23 |
ASX - By Stock
|
7
|
2.1K
|
4
|
|
ASX - By Stock
|
ACW |
Re:
ACW general discussion
|
|
Lait
|
160 |
73K |
2 |
14/12/22 |
14/12/22 |
ASX - By Stock
|
160
|
73K
|
2
|
|
ASX - By Stock
|
ACW |
Re:
ACW general discussion
|
|
Lait
|
160 |
73K |
10 |
06/12/22 |
06/12/22 |
ASX - By Stock
|
160
|
73K
|
10
|
|
ASX - By Stock
|
ACW |
Re:
Ann: ACW CEO presentation to Bell Potter Healthcare Conference
|
|
Lait
|
4 |
1.7K |
4 |
09/11/22 |
09/11/22 |
ASX - By Stock
|
4
|
1.7K
|
4
|
|
ASX - By Stock
|
MX1 |
Re:
Ann: MX1 - Quarterly Cashflow and Activities Statement
|
|
Lait
|
15 |
4.4K |
4 |
09/11/22 |
09/11/22 |
ASX - By Stock
|
15
|
4.4K
|
4
|
|
ASX - By Stock
|
EMV |
Re:
EMvision Research Notes
|
|
Lait
|
2.4K |
1.1M |
2 |
09/11/22 |
09/11/22 |
ASX - By Stock
|
2.4K
|
1.1M
|
2
|
|
ASX - By Stock
|
MX1 |
Re:
Argus launch article
|
|
Lait
|
9 |
4.2K |
1 |
10/09/22 |
10/09/22 |
ASX - By Stock
|
9
|
4.2K
|
1
|
|
ASX - By Stock
|
MX1 |
Re:
Ann: MX1 - Quarterly Cash Flows and Activities Statement
|
|
Lait
|
17 |
8.1K |
7 |
10/08/22 |
10/08/22 |
ASX - By Stock
|
17
|
8.1K
|
7
|
|
ASX - By Stock
|
MX1 |
Re:
Ann: MX1 - $8M contract signed with Australian Stroke Alliance
|
|
Lait
|
22 |
9.7K |
5 |
17/10/21 |
17/10/21 |
ASX - By Stock
|
22
|
9.7K
|
5
|
|
ASX - By Stock
|
MX1 |
Re:
Quickstep announcement
|
|
Lait
|
15 |
7.3K |
8 |
15/08/21 |
15/08/21 |
ASX - By Stock
|
15
|
7.3K
|
8
|
|